Omalizumab treatment reduces asthma exacerbations regardless of airway bronchodilator reversibility.

J Allergy Clin Immunol Pract

Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, Colo. Electronic address:

Published: August 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaip.2022.04.029DOI Listing

Publication Analysis

Top Keywords

omalizumab treatment
4
treatment reduces
4
reduces asthma
4
asthma exacerbations
4
exacerbations airway
4
airway bronchodilator
4
bronchodilator reversibility
4
omalizumab
1
reduces
1
asthma
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!